Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
Psychiatry and Clinical Psychopharmacology|May 20, 2024
Left Cerebral Cortex Complexity in Patients with Major Depression Disorder: A Small-Sample Pilot StudyJian Liu, Xinying Chen, Chuanxin Liu, et al.Psychiatry and Clinical Psychopharmacology|May 20, 2024
Unstructured Group Support Enhances Compliance to Pharmacological Treatment by Improving Social Cognition in Patients with Bipolar Disorder: A Pilot fMRI StudyYing Wang, Yonghui Zhang, Hongjun Tian, et al.Psychiatry and Clinical Psychopharmacology|May 20, 2024
Plasma Orexin Levels Related to Altered Brain Activity During Abstinence in Patients with Alcohol DependenceJianshe Pan, Guangdong Chen, Peiwei Shan, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 19, 2020
Reciprocal deterioration of visual and auditory hallucinations in schizophrenia presents V-shaped cognition impairment and widespread reduction in brain gray matter-A pilot studyChuanjun Zhuo, Min Chen, Yong Xu, et al.Neuroscience Letters|May 18, 2020
Depressive symptoms combined with auditory hallucinations are accompanied with severe gray matter brain impairments in patients with first-episode untreated schizophrenia - A pilot study in ChinaChuanjun Zhuo, Xuexin Xu, Xiaodong Lin, et al.Frontiers in Psychiatry|October 31, 2022
Baseline global brain structural and functional alterations at the time of symptom onset can predict subsequent cognitive deterioration in drug-naïve first-episode schizophrenia patients: Evidence from a follow-up studyChuanjun Zhuo, Guangdong Chen, Jiayue Chen, et al.Frontiers in Psychiatry|October 7, 2022
Testing the validity and reliability of the Chinese version of the Staden schizophrenia anxiety rating scaleChenyuan Du, Jiayue Chen, Xiaoyan Ma, et al.Neuropsychiatric Disease and Treatment|February 5, 2021
Irreversible Primary Visual Cortex Impairment in a Mouse Model of High-Risk SchizophreniaXinying Chen, Ce Chen, Feng Ji, et al.The Journal of International Medical Research|April 23, 2019
Aberrant functional connectivity density in patients with treatment-refractory obsessive-compulsive disorder: a pilot studyPei Wei Shan, Wei Liu, Caixing Liu, et al.Psychiatry Research|March 18, 2020
Ketamine plus propofol-electroconvulsive therapy (ECT) transiently improves the antidepressant effects and the associated brain functional alterations in patients with propofol-ECT-resistant depressionJianjing Zhang, Hongjun Tian, Jie Li, et al.Pageof 6